--- license: cc-by-nc-sa-4.0 pretty_name: VALDO — Vascular Lesions Detection and Segmentation (MICCAI 2021) task_categories: - image-segmentation tags: - medical-imaging - mri - brain - cerebral-small-vessel-disease - perivascular-spaces - cerebral-microbleeds - lacunes - neuroimaging size_categories: - n<1K dataset_info: features: - name: task dtype: string - name: subject_id dtype: string - name: cohort dtype: string - name: lesion_type dtype: string - name: reference_space dtype: string - name: has_segmentation dtype: bool - name: n_rater_masks dtype: int32 - name: gt_rule dtype: string - name: mask_voxels dtype: int64 - name: slice_idx dtype: int32 - name: num_slices dtype: int32 - name: ref_other_name dtype: string - name: image_T1 dtype: image - name: image_T2 dtype: image - name: image_ref_other dtype: image - name: mask dtype: image - name: overlay dtype: image splits: - name: task1_epvs num_bytes: 9742157 num_examples: 40 - name: task2_cmb num_bytes: 13932473 num_examples: 72 - name: task3_lacunes num_bytes: 9849342 num_examples: 40 download_size: 33549282 dataset_size: 33523972 configs: - config_name: default data_files: - split: task1_epvs path: data/task1_epvs-* - split: task2_cmb path: data/task2_cmb-* - split: task3_lacunes path: data/task3_lacunes-* --- # VALDO — "Where is VALDO?" VAscular Lesions DetectiOn and segmentatiOn challenge (MICCAI 2021) > **⚠️ This repository is the publicly-released *training set only* of VALDO 2021.** > The challenge had **431 cases total (152 train + 279 test)**; the **279-case test set was never publicly > distributed** (the organisers evaluate submitted Docker containers on a held-out server). What you see here is > the **152-case training release** from Zenodo — the only portion the authors made openly downloadable. > > **⚠️ Preprocessed-for-challenge variant, not raw acquisitions.** All images are **defaced**, and within each > task the non-reference sequences are **rigidly/affinely co-registered and resampled** to the task's reference > space (T1 for Tasks 1 & 3, T2\* for Task 2). VALDO targets three imaging markers of **cerebral small vessel disease (CSVD)** on brain MRI, organised as three independent tasks. Data is drawn from three population cohorts: **SABRE** (London), **RSS = Rotterdam Scan Study** (part of the Rotterdam Study), and **ALFA** (BarcelonaBeta, Task 2 only). ## Tasks & contents Layout is BIDS-like: `Task{1,2,3}/sub-XXX/` with files named `sub-{ID}_space-{Space}_desc-{Description}_{Suffix}.nii.gz`. ### Task 1 — Enlarged Perivascular Spaces (EPVS) · 40 subjects · T1 space | Suffix | Role | |---|---| | `desc-masked_T1` / `desc-masked_T2` / `desc-masked_FLAIR` | images (T2/FLAIR co-registered to T1, defaced) | | `desc-masked_Regions` | region mask: each region a distinct integer, keyed to `Count.csv` | | `Count.csv` | per-region EPVS counts (`value, count, min_slice, max_slice`; slices 0-indexed) | | `desc-Rater{1,2}_PVSSeg` / `PVSSeg` | EPVS segmentation — **present for only 12 of 40 subjects** | > **Heterogeneous / weak-label task.** Of 40 subjects: **6 (SABRE, sub-101…106)** have voxel segmentations from > **two raters** (`desc-Rater1/Rater2_PVSSeg`); **6 (RSS)** have a **single** `PVSSeg`; the remaining **28 (RSS)** > have **counts only** (`Count.csv` + `Regions`, **no segmentation mask**). A segmentation loader must filter to > the 12 subjects with a `PVSSeg` file; the 28 counts-only cases are a deliberate weak-supervision tier. ### Task 2 — Cerebral Microbleeds (CMB) · 72 subjects · T2\* space | Suffix | Role | |---|---| | `desc-masked_T2S` / `desc-masked_T2` / `desc-masked_T1` | images (T2/T1 co-registered to T2\*, defaced) | | `CMB` | microbleed segmentation — **70 of 72 subjects** carry a mask | > 2 subjects have no `CMB` file (treat as zero-microbleed / empty-mask cases). Cohorts: SABRE, RSS, ALFA. ### Task 3 — Lacunes · 40 subjects · T1 space | Suffix | Role | |---|---| | `desc-masked_T1` / `desc-masked_T2` / `desc-masked_FLAIR` | images (T2/FLAIR co-registered to T1, defaced) | | `desc-Rater{1,2,3,4}_Lacunes` | lacune segmentation — **two raters per subject** | > **Every** subject has exactly **two** rater masks, but the rater *identity differs by cohort*: > **SABRE (sub-101…106)** uses `Rater1`+`Rater2`; **RSS (sub-201+)** uses `Rater3`+`Rater4`. A loader must pick > whichever two `*_Lacunes` files exist per subject — do **not** hardcode `Rater1`/`Rater2`. One subject > (`sub-105`) additionally carries a `sub-105_space-T1_possible.nii.gz` ("possible lacunes") auxiliary mask. ## Gold-standard ground truth (paper's consensus rule) Where **two rater masks** exist (Task 3 all cases; Task 1 SABRE sub-101…106), the reference standard is the **average of the two raters' masks, thresholded at 0.5** (binary). Where a single mask exists (Task 1 RSS single `PVSSeg`; Task 2 `CMB`), that mask is the ground truth. **All rater masks are preserved here** so this rule can be applied — or revised — downstream. ## ⚠️ Cross-cohort lineage (leakage note) VALDO subjects come from **SABRE**, **RSS (Rotterdam Scan Study)**, and **ALFA** population cohorts. There is **no overlap** with tumor/oncology benchmarks (BraTS family, Medical Segmentation Decathlon, TCIA collections). The one lineage to watch is **RSS / the Rotterdam Study**, which contributes to many neuroimaging datasets — de-duplicate before combining VALDO with any other Rotterdam-derived set. **No cross-reference ID column is exposed**: subject IDs are challenge-local (`sub-###`) and original cohort IDs are not released, so subject-level linking is not directly possible from these files. ## License The Zenodo record's metadata states **CC BY-NC 4.0**, while the paper and the original README state **CC BY-NC-SA** (NonCommercial-**ShareAlike**). We adopt the **more restrictive non-commercial + share-alike** interpretation (`cc-by-nc-sa-4.0`). Either way the data is **non-commercial use only**. ## Provenance Official author release — Zenodo record **10.5281/zenodo.4520773** (the challenge organisers' own deposit, linked from https://valdo.grand-challenge.org/). Public training counts (Task1=40, Task2=72, Task3=40 → 152) match the paper's Table 2 exactly. Not a third-party re-host. Re-distributed here under the source non-commercial license. ## Citation Sudre, C.H., Van Wijnen, K., Dubost, F., et al. *"Where is VALDO? VAscular Lesions Detection and segmentatiOn challenge at MICCAI 2021."* Medical Image Analysis, 91:103029, 2024. https://doi.org/10.1016/j.media.2023.103029 (preprint arXiv:2208.07167). Challenge: https://valdo.grand-challenge.org/ · Data: https://zenodo.org/records/4520773